Matthew Smeltzer

418 total citations
52 papers, 264 citations indexed

About

Matthew Smeltzer is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Matthew Smeltzer has authored 52 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 11 papers in Genetics. Recurrent topics in Matthew Smeltzer's work include Lung Cancer Diagnosis and Treatment (24 papers), Global Cancer Incidence and Screening (18 papers) and Lung Cancer Treatments and Mutations (13 papers). Matthew Smeltzer is often cited by papers focused on Lung Cancer Diagnosis and Treatment (24 papers), Global Cancer Incidence and Screening (18 papers) and Lung Cancer Treatments and Mutations (13 papers). Matthew Smeltzer collaborates with scholars based in United States, Japan and United Kingdom. Matthew Smeltzer's co-authors include Raymond U. Osarogiagbon, Nicholas R. Faris, Meredith Ray, Jane S. Hankins, Meghan M. Taylor, Russell E. Ware, Banu Aygün, Jeffrey Glassberg, Lisa M. Klesges and Rita Masese and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Matthew Smeltzer

42 papers receiving 261 citations

Peers

Matthew Smeltzer
Wendy Vogel United States
Adane F. Wogu United States
Taylor D. Ellington United States
Justin Jee United States
Matthew Smeltzer
Citations per year, relative to Matthew Smeltzer Matthew Smeltzer (= 1×) peers Avinash Pandey

Countries citing papers authored by Matthew Smeltzer

Since Specialization
Citations

This map shows the geographic impact of Matthew Smeltzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Smeltzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Smeltzer more than expected).

Fields of papers citing papers by Matthew Smeltzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Smeltzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Smeltzer. The network helps show where Matthew Smeltzer may publish in the future.

Co-authorship network of co-authors of Matthew Smeltzer

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Smeltzer. A scholar is included among the top collaborators of Matthew Smeltzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Smeltzer. Matthew Smeltzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ray, Meredith, et al.. (2023). Institution-Level Evolution of Lung Cancer Resection Quality With Implementation of a Lymph Node Specimen Collection Kit. Journal of Thoracic Oncology. 18(7). 858–868.
2.
Osarogiagbon, Raymond U., et al.. (2023). Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta. JAMA Network Open. 6(2). e230787–e230787. 11 indexed citations
3.
Ray, Meredith, et al.. (2023). Program-Based Lung Cancer Care: A Prospective Observational Tumor Registry Linkage Study. JTO Clinical and Research Reports. 5(2). 100629–100629. 1 indexed citations
4.
Shao, Huibo, Nicholas R. Faris, Kenneth D. Ward, et al.. (2023). Lung Cancer Patients’ and Caregivers’ Satisfaction With Multidisciplinary Versus Serial Care in a Community Healthcare Setting: A Prospective Comparative-Effectiveness Cohort Study. Clinical Lung Cancer. 24(7). e267–e274. 2 indexed citations
5.
Hankins, Jane S., Robert L. Davis, Amanda Young, et al.. (2023). Descriptive epidemiology of sickle cell disease in Tennessee: population-based estimates from 2008 to 2019. SHILAP Revista de lepidopterología. 2.
6.
Smeltzer, Matthew, Giorgio V. Scagliotti, Heather A. Wakelee, et al.. (2022). International Association for the Study of Lung Cancer Study of the Impact of Coronavirus Disease 2019 on International Lung Cancer Clinical Trials. Journal of Thoracic Oncology. 17(5). 651–660. 5 indexed citations
7.
Smeltzer, Matthew, et al.. (2022). Potential Impact of Criteria Modifications on Race and Sex Disparities in Eligibility for Lung Cancer Screening. Journal of Thoracic Oncology. 18(2). 158–168. 17 indexed citations
8.
Nolan, Val, Matthew Smeltzer, Fawaz Mzayek, et al.. (2022). Energy cost of walking in obese survivors of acute lymphoblastic leukemia: A report from the St. Jude Lifetime Cohort. Frontiers in Pediatrics. 10. 976012–976012. 1 indexed citations
9.
Smeltzer, Matthew, et al.. (2021). Three Wishes for Sickle Cell Disease: Results from a multi-stakeholder vision-casting project in Tennessee. 11(2). e21014–e21014. 1 indexed citations
10.
Ray, Meredith, et al.. (2021). Comparative Effectiveness of a Lymph Node Collection Kit Versus Heightened Awareness on Lung Cancer Surgery Quality and Outcomes. Journal of Thoracic Oncology. 16(5). 774–783. 9 indexed citations
11.
Smeltzer, Matthew, et al.. (2021). Intranasal Fentanyl and Midazolam Use in Children 3 Years of Age and Younger in the Emergency Department. Journal of Emergency Medicine. 61(6). 731–739. 2 indexed citations
12.
Ray, Meredith, Nicholas R. Faris, Matthew Smeltzer, et al.. (2021). Survival Impact of an Enhanced Multidisciplinary Thoracic Oncology Conference in a Regional Community Health Care System. JTO Clinical and Research Reports. 2(8). 100203–100203. 9 indexed citations
14.
Osarogiagbon, Raymond U., Matthew Smeltzer, Nicholas R. Faris, et al.. (2021). Outcomes After Use of a Lymph Node Collection Kit for Lung Cancer Surgery: A Pragmatic, Population-Based, Multi-Institutional, Staggered Implementation Study. Journal of Thoracic Oncology. 16(4). 630–642. 17 indexed citations
15.
Ray, Meredith, Matthew Smeltzer, Nicholas R. Faris, & Raymond U. Osarogiagbon. (2020). Survival After Mediastinal Node Dissection, Systematic Sampling, or Neither for Early Stage NSCLC. Journal of Thoracic Oncology. 15(10). 1670–1681. 30 indexed citations
16.
Minden‐Birkenmaier, Benjamin A., Meghan M. Taylor, Matthew Smeltzer, et al.. (2020). Manuka honey modulates the release profile of a dHL-60 neutrophil model under anti-inflammatory stimulation. Journal of Tissue Viability. 29(2). 91–99. 15 indexed citations
17.
Ray, Meredith, et al.. (2020). Rurality, Stage-Stratified Use of Treatment Modalities, and Survival of Non-small Cell Lung Cancer. CHEST Journal. 158(2). 787–796. 26 indexed citations
18.
Faris, Nicholas R., Yu-Sheng Lee, Meghan M. Taylor, et al.. (2017). P1.01-021 The Impact of Smoking Status on Overall Survival in a Population-Based Non-Small Cell Lung Cancer (NSCLC) Surgical Resection Cohort. Journal of Thoracic Oncology. 12(1). S461–S461. 1 indexed citations
19.
Osarogiagbon, Raymond U., Chun Chieh Lin, Matthew Smeltzer, & Ahmedin Jemal. (2015). Incomplete non-small-cell lung cancer (NSCLC) resections in the National Cancer Data Base (NCDB): Predictors, prognosis and value of adjuvant therapy.. Journal of Clinical Oncology. 33(15_suppl). 7527–7527. 2 indexed citations
20.
Sachdev, Jasgit C., et al.. (2014). A phase II study of temsirolimus in previously treated advanced hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 32(15_suppl). 4098–4098. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026